UAlberta research informs US guidelines on gestational diabetes

July 15, 2013
Lisa Hartling

Medical researchers at the University of Alberta are providing their expertise to the U.S. government to help guide recommendations on gestational diabetes screening.

Lisa Hartling, a researcher in the U of A's Faculty of Medicine & Dentistry, recently published her team's work comparing different approaches to screening for and the impact of treatment. The findings were presented to the U.S. National Institutes of Health and the U.S. Preventive Services Task Force, which would like to see standardized screening and diagnosis of gestational across the United States. The findings were also published earlier this year in the peer-reviewed journal Annals of Internal Medicine.

The research was funded by the U.S. government via the Agency for Healthcare Research and Quality to provide evidence for recommendations about how to best screen for and diagnose gestational diabetes. The agencies involved also wanted to identify the harms and benefits of treating for gestational diabetes. There are 11 centres in North America that do this type of evidence-based research for the Agency for Healthcare Research and Quality. Hartling's team is the only such group in Canada and was chosen because of their expertise and knowledge in this area.

Hartling's team reported on the variations in screening recommendations by different organizations around the world. For example, some recommend that pregnant women undergo two tests. If the first registers high levels of glucose, then patients go for a second, more definitive test. Other organizations recommend pregnant women receive only one test. Some organizations screen all for gestational diabetes, whereas others only screen women who exhibit risk factors.

The team found that a fasting blood test was very effective at ruling women out for gestational diabetes. Another test, in which women drink a sugary drink before a blood test, was better at pinpointing those who had gestational diabetes. This sugary-drink test resulted in fewer false positives, although many still occur.

"In medical research, you ideally want to find the tests that are most effective at both pinpointing those who have a condition and identifying those who don't have the condition," Hartling explains.

"There is no gold-standard test for this condition, which is why so many organizations have come up with different approaches on how to test for gestational diabetes. The National Institutes of Health would like to see some of these controversies resolved. They aim to develop a consensus statement to guide practice in the United States."

The potential downsides identified to treating women for gestational diabetes—through glucose monitoring, modified diets and insulin if needed—were increased costs and the possibility of more apprehension over the "label" of gestational diabetes. For example, some studies show that care for women with gestational diabetes may be more precautionary, such as inducing labour and admitting babies to neonatal intensive care.

Hartling and her team also examined whether mothers and their babies experienced health improvements when gestational diabetes was treated. They found that the benefits were many, including fewer delivery problems, more healthy-sized babies and less incidence of high blood pressure for mothers.

Explore further: New test assesses gestational diabetes risk early in pregnancy

Related Stories

New test assesses gestational diabetes risk early in pregnancy

May 29, 2013
Levels of a biomarker in a pregnant woman's blood can help physicians gauge her risk of developing gestational diabetes during the first trimester, according to a recent study accepted for publication in The Endocrine Society's ...

Task force: Screen for gestational diabetes after 24 weeks of pregnancy

May 27, 2013
(HealthDay)—All women should be screened for gestational diabetes after 24 weeks of pregnancy regardless of whether they have symptoms of the condition, according to a new draft recommendation statement issued by the U.S. ...

Common pregnancy conditions risk future diabetes

April 16, 2013
Two common conditions in pregnancy may be risk factors for future diabetes according to a Canadian study of over one million women published in this week's PLOS Medicine.

Do more women need diabetes care when pregnant?

March 6, 2013
Developing diabetes during pregnancy isn't good for mother or baby, and it's a growing problem. Now there's a push to change how women are tested for the disorder. But a government panel warns that would label a lot more ...

Pre-pregnancy diabetes increases risk of MRSA among new mothers

July 1, 2013
Pregnant women with diabetes are more than three times as likely as mothers without diabetes to become infected with methicillin-resistant Staphylococcus aureus (MRSA) before hospital discharge, according to a study in the ...

Study finds up to half of gestational diabetes patients will develop type 2 diabetes

March 7, 2013
Women who were diagnosed with gestational diabetes during pregnancy face a significantly higher risk of developing Type 2 diabetes in the future, according to a recent study accepted for publication in The Endocrine Society's ...

Recommended for you

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Time to dial back on diabetes treatment in older patients? Study finds 11 percent are overtreated

September 14, 2017
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.